This latest GenomeWeb win reinforces Genomenon’s position as the employer of choice for high-impact genomic talent.
ANN ARBOR, MICH. - November 19, 2025 - FOR IMMEDIATE RELEASE
In a market where world-class talent is the only durable advantage, Genomenon®, Inc. today announced that it has been named one of GenomeWeb’s Best Places to Work for the second year in a row in the 51-100 employee category.
This “two-peat” recognition is based on direct employee feedback and positions Genomenon as a destination of choice for scarce genomic, data science, and commercial talent, reinforcing the company’s ability to execute on its genomic intelligence and literature-derived real-world evidence (RWE) strategy.
“We are so grateful that Genomenon has been recognized again because of our commitment to building a culture where people feel seen, valued, and connected to meaningful work,” said Erin McCann, the company’s head of people. “Our mission is a powerful motivator, and we make sure every role ties back to that impact.”
Behind the award is a deliberate operating system engineered to concentrate and compound talent. Over the past year, Genomenon has sharpened that system by:
Genomenon has also deepened its community and rare disease engagement, pairing awareness campaigns with action through free curated variant insights for researchers, ongoing internship and mentoring programs, and its virtual Summer Camp, which connects employees directly with advocates and families impacted by rare diseases.
“Everyone at Genomenon is an equity stakeholder,” McCann said. “We encourage every team member to act, and feel, like an owner.” That ownership mindset, grounded in empathy and purpose, continues to define how the company grows, connects, and leads.
About Genomenon
Genomenon is a genomic intelligence company transforming patient care by uncovering the genomic drivers of genetic disease and cancer. By combining the power of AI built on a comprehensive genomic dataset with deep scientific expertise, Genomenon delivers structured, actionable insights that support advanced patient diagnosis and accelerate precision medicine development. Its integrated software, data, and services solutions empower biopharma and clinical partners worldwide.
Follow us on LinkedIn for the latest news and updates.
GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb is a family brand of Crain Communications.
GenomeWeb’s editorial mission is to cover the scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing. We operate the largest online newsroom focused on advanced molecular research tools in order to provide our readers with exclusive news and in-depth analysis of this rapidly evolving market.
GenomeWeb users can be found in major scientific organizations around the world, including biopharmaceutical companies, research universities, biomedical institutes, clinical labs, and government laboratories. Our advertisers include leading suppliers of research tools, analytical instruments, information technology, and molecular diagnostics.
